Company: LXP
Filing Date: 2025-04-15
Form Type: DEF 14A
Source: 0001539497-25-001131
Chunk: 8

Company: LXP Industrial Trust
Filing Date: 2025-04-15
Form: DEF 14A
Chunk 8
---
 and Exchange Commission (which disclosure includes the Compensation</div>

| 8 |

<div align='center'>Discussion and Analysis, the Summary Compensation Table and accompanying compensation tables and related information).” The advisory resolution to approve the compensation of our named executive officers requires a majority of the votes cast on the proposal at the Annual Meeting. Although the vote on this Proposal No. 2 is a nonbinding, advisory vote, the Board of Trustees will carefully consider the voting results.</div>

| THE BOARD OF TRUSTEES UNANIMOUSLY          
 RECOMMENDS                                 
 THAT SHAREHOLDERS VOTE FOR PROPOSAL NO. 2. |

<div align='center'>PROPOSAL NO. 3 APPROVAL OF AN AMENDMENT TO THE LXP
INDUSTRIAL TRUST 2022 EQUITY-BASED AWARD PLAN TO
INCREASE THE NUMBER OF SHARES AVAILABLE FOR
ISSUANCE THEREUNDER BY 5,000,000 COMMON SHARES On April 3, 2025 the Compensation Committee of our Board of Trustees adopted an amendment to the LXP Industrial Trust 2022 Equity-Based Award Plan to increase the number of shares available for issuance thereunder by 5,000,000 common shares, which equates to approximately 1.7% of our common shares outstanding. We refer to the LXP Industrial Trust 2022 Equity-Based Award Plan as amended prior to the recently adopted amendment as the 2022 Plan, the amendment to the 2022 Plan as the 2022 Plan Amendment, and the 2022 Plan as amended by the 2022 Plan Amendment as the 2022 Amended Plan. The 2022 Plan Amendment is subject to approval at the Annual Meeting. A summary of the principal provisions of the 2022 Plan Amendment begins on page 55 of this Proxy Statement. The full text of the 2022 Plan Amendment and the 2022 Plan are attached as Appendix B to this Proxy Statement and is incorporated by reference into this proposal. As of the Record Date, 428,213 common shares remained available for grant under the 2022 Plan and 4,198,859 common shares were subject to outstanding awards under the 2022 Plan, including 3,080,471 performance-based non-vested shares issued at the maximum award. The 2022 Amended Plan authorizes the issuance of the sum of (x) the additional 5,000,000 common shares, (y) the common shares remaining available for